Severe hypertriglyceridaemia in horses and ponies with endocrine disorders.

REASONS FOR PERFORMING THE STUDY: Severe hypertriglyceridaemia in horses and ponies with endocrine disorders has been reported anecdotally but has not been documented in the literature. OBJECTIVES: To describe historical and clinicopathological findings as well as progression and outcome in horses and ponies with severe hypertriglyceridaemia (serum triglyceride concentration >5.65 mmol/l) secondary to an endocrine disorder that were otherwise apparently healthy. METHODS: Cases from 6 participating institutions were identified and case details extracted from the medical records. RESULTS: Case details of 3 horses and 4 ponies were available. Presenting complaints included weight loss despite good appetite in 4 animals, while in 3 hypertriglyceridaemia was identified incidentally. All animals were bright and alert and showed a normal or increased appetite. Serum triglyceride concentrations ranged from 10.5 to 60.3 mmol/l. Other abnormalities included hyperglycaemia in 6 animals, suspected insulin resistance and mild to severe increases in hepatic enzyme activities. In 2 animals, moderate hepatic lipidosis was confirmed histologically. Three horses and 3 ponies were diagnosed with pituitary pars intermedia dysfunction based on clinical signs and basal adrenocorticotropic hormone (ACTH) concentrations or dexamethasone suppression test results. In 5 of these, type 2 diabetes mellitus was also confirmed, while one pony suffered from type 2 diabetes mellitus without concurrent pituitary pars intermedia dysfunction. Laboratory abnormalities improved in 4 animals with treatment (pergolide and/or insulin), in one horse specific treatment was not attempted, and in 2 ponies treatment was impaired by the owner or only partly effective. In one of the latter cases, biochemical abnormalities persisted for 7 years without apparent ill effects. CONCLUSIONS AND POTENTIAL RELEVANCE: Horses and ponies may develop severe hypertriglyceridaemia secondary to endocrine disorders that are associated with insulin resistance. Hypertriglyceridaemia can resolve with treatment of the endocrinopathy. Although biochemical evidence of hepatic compromise was present, clinical abnormalities were not noted in these animals.

Periodontal bone loss in mice induced by different periodontopathic organisms.

Periodontal bone loss in mice orally inoculated with Peptostreptococcus anaerobius, Pept. magnus and Actinobacillus actinomycetemcomitans was compared to that in sham-inoculated mice. Six-to-8-week-old BALB/c mice were inoculated with 1 x 10(5), 1 x 10(7) or 1 x 10(9) colony-forming units (c.f.u.) of bacteria in 50 microliters of medium. Ten mice received each concentration of bacteria and 10 sham-inoculated mice acted as controls. Five mice from each of the groups were killed 6 weeks after inoculation and the remaining five mice at 12 weeks. Right hemimandibles were defleshed, stained and bone loss was measured using an image analyser. All the organisms tested were associated with bone loss. Animals that had received Pept. anaerobius and Pept. magnus had up to 18% more bone loss than those sham inoculated. In contrast, mice inoculated with A. actinomycetemcomitans had up to 38% more bone loss than the sham-inoculated animals, this amount of loss occurring at the lowest inoculation of 1 x 10(5) c.f.u. These data demonstrate a differential ability of micro-organisms to cause periodontal bone loss in mice.

Illness among holidaymakers and the effect on a seaside practice.

Between 1 May and 30 September 1983 a practice of three doctors in the centre of Scarborough conducted 1772 consultations with 1472 temporary residents, 967 (55%) of which were during July and August. The pattern of illness differed considerably from that usually found in general practice, with an excess of minor infections, gastrointestinal upsets, and skin problems comprising 46% of the consultations. Practitioners who care for appreciable numbers of temporary residents should plan their services to match the special needs of holidaymakers. The task of doctors in areas with many visitors would be made easier if patients who are on regular medication or are under surveillance brought with them not only enough drugs for their needs but also a summary of their medical history.

Binding of mouse peritoneal macrophages to tumour cells by a "lectin-like" macrophage receptor.

A binding interaction is described between mouse peritoneal macrophages, tumour cells and proliferating mouse embryo fibroblasts. The interaction appears to be between a "lectin-like" receptor in the macrophage plasma membrane and carbohydrates in the plasma membrane of the target cells.